Healthcare Technologies
This article was originally published in The Tan Sheet
Executive Summary
Uriscreen urinary tract infection home diagnostic test kit for OTC marketing gains FDA approval Oct. 7, Ashdod, Israel-based firm's Savyon Diagnostics subsidiary says. "With increased availability of treatments that offer women immediate relief from the painful symptoms of UTI, more women are seeking home screening procedures," Healthcare Technologies says. Uriscreen, which measures catalase, has a 91% accuracy level, the firm adds. Healthcare is in negotiations with a "major" pharmaceutical firm regarding North American distribution of the product, which would be marketed under the undisclosed firm's name